OSCR

Lack of cortistatin drives neuroimmune and vascular dysfunction in brain ischemia.

Overview

Authors: Julia Castillo-González1,2,3, Pablo Vargas-Rodríguez1, Ignacio Serrano-Martínez1, Alejandro Cuenca-Martagón1, Irene Forte-Lago1, Melanie Price2,3, Lara Buscemi2,3, Lorenz Hirt2,3, José Luis Ruiz1,4,5, Elena González-Rey1
  1. Institute of Parasitology and Biomedicine (IPBLN-CSIC), Granada, Spain
  2. University of Lausanne, Lausanne, Switzerland
  3. Lausanne University Hospital, Lausanne, Switzerland
  4. Functional Genomics Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland
  5. Swiss Institute of Bioinformatics, Amphipôle, Quartier UNIL-Sorge, Lausanne, Switzerland
Journal: Journal of biomedical science, volume 33, issue 1, article 65
Dates: received 3 February 2026; accepted 13 June 2026; published online 20 June 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1186/s12929-026-01271-w · PMID 42321803 · PMCID PMC13282875 · OpenAlex W7165380832
Open access: diamond, a free copy (OpenAlex)
Categories: human (organism), mouse (organism), stroke (population), cellular / molecular (subfield)
Methods: Spectral & time-frequency, Statistics, Machine learning, Connectivity, Complexity
Keywords: Ischemic stroke, Cortistatin, Neuroimmunology, Microglia, Astrocytes, Neuroinflammation, Blood–brain barrier
MeSH: Brain Ischemia*, Neuroimmunomodulation*, Neuroinflammatory Diseases*, Neuropeptides*, Animals, Disease Models, Animal, Humans, Male, Mice, Mice, Inbred C57BL (* major topic)
Topic: Neuroinflammation and Neurodegeneration Mechanisms (Neurology, Neuroscience), according to OpenAlex
Funding: Swiss National Science Foundation (310030, FNS 310030_212233, 212233); Spanish Ministry of Economy and Competitiveness (MCIN)/Spanish Research Agency (AEI)/10.13039/501100011033 (PRE2021-100172, PRE2018-084824, SAF2017-85602-R, FPU17/02616); Ministry of Economy and Competitiveness (MCIN)/Spanish Research Agency (AEI)/10.13039/501100011033 (FPU23/00152); Regional Andalusian Government (PROYEXCEL_00867); the Spanish Ministry of Economy and Competitiveness (MCIN)/Spanish Research Agency (AEI)/10.13039/501100011033 (PID2020-119638RB-I00); Fundación Ramón Areces (Post-doctoral fellowship)
Citations: not cited yet (Europe PMC); 113 references in the paper

Abstract

Background: Ischemic stroke remains a leading cause of death and disability, with limited therapies addressing its pathophysiology. Neuroinflammation, blood–brain barrier disruption, and immune dysregulation critically contribute to both acute neuronal injury and chronic functional decline. Elucidating the endogenous factors that govern these processes and understanding the intricate interplay among them is essential for developing effective therapeutic strategies. Cortistatin, a neuropeptide expressed in the nervous and immune systems, exhibits potent immunomodulatory actions, but its role in neuroinflammatory diseases remains unclear.

Methods: In this study, we combined human and murine transcriptomic analyses with a preclinical stroke model in cortistatin-deficient mice to investigate the endogenous and therapeutic roles of cortistatin during the acute (48 h) and subacute (7 days) phases of ischemic stroke.

Results: We demonstrate for the first time that cortistatin deficiency amplified ischemia-induced transcriptional programs, heightening neuroinflammation and glial/neurovascular dysfunction, and worsening neurological outcomes. Interestingly, cortistatin deficiency accelerated aging-associated pathological features, underscoring its essential role in neuroimmune and cerebrovascular homeostasis. Conversely, cortistatin administration improved neuronal survival, mitigated immune dysfunction, and preserved myelin and vascular integrity during both the acute and subacute stages.

Conclusions: These findings provide the first evidence identifying cortistatin as an endogenous neuroimmune regulator in ischemic stroke and a promising multimodal therapeutic agent for improving acute and long-term outcomes.

Supplementary Information: The online version contains supplementary material available at 10.1186/s12929-026-01271-w.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability

RNA-seq data are available in the GEO repository under accession number GSE302342 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302342), https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302342.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 10 authors, 7 keywords, 10 MeSH terms, 6 funders, 111 references.

Cite

This paper

Castillo-González, J., Vargas-Rodríguez, P., Serrano-Martínez, I., Cuenca-Martagón, A., Forte-Lago, I., Price, M., Buscemi, L., Hirt, L., Ruiz, J. L., & González-Rey, E. (2026). Lack of cortistatin drives neuroimmune and vascular dysfunction in brain ischemia. Journal of biomedical science, 33(1), 65. https://doi.org/10.1186/s12929-026-01271-w

BibTeX

@article{castillogonzalez2026lack,
author = {Castillo-González, Julia and Vargas-Rodríguez, Pablo and Serrano-Martínez, Ignacio and Cuenca-Martagón, Alejandro and Forte-Lago, Irene and Price, Melanie and Buscemi, Lara and Hirt, Lorenz and Ruiz, José Luis and González-Rey, Elena},
title = {{Lack of cortistatin drives neuroimmune and vascular dysfunction in brain ischemia}},
journal = {Journal of biomedical science},
year = {2026},
month = jun,
volume = {33},
number = {1},
pages = {65},
publisher = {BMC},
issn = {1021-7770},
doi = {10.1186/s12929-026-01271-w},
url = {https://doi.org/10.1186/s12929-026-01271-w},
pmid = {42321803},
pmcid = {PMC13282875}
}

RIS

TY - JOUR
AU - Castillo-González, Julia
AU - Vargas-Rodríguez, Pablo
AU - Serrano-Martínez, Ignacio
AU - Cuenca-Martagón, Alejandro
AU - Forte-Lago, Irene
AU - Price, Melanie
AU - Buscemi, Lara
AU - Hirt, Lorenz
AU - Ruiz, José Luis
AU - González-Rey, Elena
TI - Lack of cortistatin drives neuroimmune and vascular dysfunction in brain ischemia
T2 - Journal of biomedical science
J2 - J Biomed Sci
PY - 2026
DA - 2026/06/20
VL - 33
IS - 1
SP - 65
SN - 1021-7770
PB - BMC
DO - 10.1186/s12929-026-01271-w
UR - https://doi.org/10.1186/s12929-026-01271-w
LA - en
ER -

CSL-JSON

{
"id": "10.1186/s12929-026-01271-w",
"type": "article-journal",
"title": "Lack of cortistatin drives neuroimmune and vascular dysfunction in brain ischemia",
"container-title": "Journal of biomedical science",
"author": [
{
"family": "Castillo-González",
"given": "Julia"
},
{
"family": "Vargas-Rodríguez",
"given": "Pablo"
},
{
"family": "Serrano-Martínez",
"given": "Ignacio"
},
{
"family": "Cuenca-Martagón",
"given": "Alejandro"
},
{
"family": "Forte-Lago",
"given": "Irene"
},
{
"family": "Price",
"given": "Melanie"
},
{
"family": "Buscemi",
"given": "Lara"
},
{
"family": "Hirt",
"given": "Lorenz"
},
{
"family": "Ruiz",
"given": "José Luis"
},
{
"family": "González-Rey",
"given": "Elena"
}
],
"container-title-short": "J Biomed Sci",
"volume": "33",
"issue": "1",
"page": "65",
"DOI": "10.1186/s12929-026-01271-w",
"PMID": "42321803",
"PMCID": "PMC13282875",
"ISSN": "1021-7770",
"publisher": "BMC",
"URL": "https://doi.org/10.1186/s12929-026-01271-w",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
20
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s12974-023-02908-5
Cortistatin deficiency reveals a dysfunctional brain endothelium with impaired gene pathways, exacerbated immune activation, and disrupted barrier integrity.
Journal: Journal of neuroinflammation
In common: mouse, cellular / molecular, 10 references, 2 authors
[2] doi:10.7150/thno.88678
LCP1 knockdown in monocyte-derived macrophages: mitigating ischemic brain injury and shaping immune cell signaling and metabolism.
Journal: Theranostics
In common: stroke, mouse, cellular / molecular, 7 references
[3] doi:10.1038/s41467-024-50465-z
Single-nucleus RNA sequencing reveals glial cell type-specific responses to ischemic stroke in male rodents.
Journal: Nature communications
In common: stroke, mouse, cellular / molecular, 6 references
[4] doi:10.18632/aging.205308
Investigating the ID3/SLC22A4 as immune-related signatures in ischemic stroke.
Journal: Aging
In common: stroke, mouse, cellular / molecular, 6 references
[5] doi:10.1007/s10565-026-10177-0
Multi-omics analysis and experimental validation reveal the IRF7-CXCL10 axis as a master regulator of microglial PCD in ischemic stroke.
Journal: Cell biology and toxicology
In common: stroke, mouse, cellular / molecular, 6 references
[6] doi:10.1038/s41467-025-59617-1
A minimally invasive thrombotic model to study stroke in awake mice.
Journal: Nature communications
In common: stroke, mouse, 5 references
[7] doi:10.15252/emmm.202216269
Systemic inflammation after stroke: implications for post-stroke comorbidities.
Journal: EMBO molecular medicine
In common: stroke, 5 references
[8] doi:10.1186/s13073-024-01368-7
Microglial heterogeneity in the ischemic stroke mouse brain of both sexes.
Journal: Genome medicine
In common: stroke, mouse, cellular / molecular, 5 references
[9] doi:10.1155/2022/3334145
Cortistatin-14 Exerts Neuroprotective Effect Against Microglial Activation, Blood-brain Barrier Disruption, and Cognitive Impairment in Sepsis-associated Encephalopathy.
Journal: Journal of immunology research
In common: mouse, cellular / molecular, 4 references
[10] doi:10.1016/j.isci.2022.104470
<i>Nt5e</i> deficiency does not affect post-stroke inflammation and lesion size in a murine ischemia/reperfusion stroke model.
Journal: iScience
In common: stroke, mouse, cellular / molecular, 5 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.